Navigation Links
BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
Date:2/28/2008

ARLINGTON, Va., Feb. 28 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com) -- the leading market research and consulting firm serving the life science industry -- announces the publication of its latest report, "Conferences & Exhibits in the Life Sciences: What's Working Now." Exhibits at scientific conferences and trade shows are an essential element of the marketing mix, but calculating return on investment (ROI) remains elusive for most vendors. This unique report compares and contrasts the perspectives of scientific customers attending conferences with the objectives and expectations of leading life science exhibitors.

"Scientific conferences can be one of the most effective ways to get in front of a large number of customers and prospects," noted Tamara Zemlo, Ph.D., Director of Syndicated Research and Analysis at BioInformatics. "We created this report to address vendors' key questions about deciding which meetings are best to attend and exhibit at, how to budget for meetings, what booth elements attract scientists, and how to ensure the best return possible."

The report has a number of encouraging findings for scientific and lab equipment suppliers. Of the 1,000 life scientists who participated in the study, only 1% claim that they do not visit exhibit halls at scientific conferences, suggesting that, in theory, vendors have an opportunity to interact with almost all of the scientists in attendance. Additionally, 76% of the scientists surveyed report that visits to exhibit halls have influenced their purchase decisions in the past 12 months.

"Vendors providing the right kind of information that scientists need, who allow them to physically examine products, and who answer their questions in an unhurried manner will be better able to positively influence the products and instruments they buy for their labs," observed Dr. Zemlo.

In addition, scientists and vendor
'/>"/>

SOURCE BioInformations, LLC
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
3. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
4. Argonne researcher studies what makes quantum dots blink
5. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
6. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Promising Data ATIR Studies Presented by NIH Investigators
9. Clemson researcher studies carbon fibers for nuclear reactor safety
10. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
11. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...swire-FirstCall/ -- Peregrine Pharmaceuticals, Inc...tient enrollment in a dose confirmation and dosime...d glioblastoma multiforme (GBM), the deadliest for...l antibody linked to a radioisotope being develope...ecifically targets cells at the center of brain tu...
(Date:12/2/2009)...December 2 Pepscan Holding NV,the...on protein mimicking,technology for the generation...s appointed Wim E.M. Mol, Ph.D. as new Chief Execu...le for all of Pepscans corporate functions and,the... company. He brings to,Pepscan more than 20 years ...
(Date:12/2/2009)...ire/ -- S*BIO Pte Ltd today announced data present...t The American Society of Hematology 51st Annual M...ill be presented on the clinical results from the ...its safety, tolerability and pharmacokinetic/pharm...from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)...FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ...tical company focused on endocrine therapy and onc... Administration (FDA) has granted Fast Track desig...r compound, perifosine (KRX-0401), for the treatme...Biopharmaceuticals, Inc. ("Keryx") ( KERX), is AEt...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...ontinues to Fortify Position in Emerging RNAi Indu... Interfering RNA (siRNA) Structural IP, PALO ALTO...eading developer of targeted, systemic RNA interfe... has licensed key intellectual,property (IP) cover... of,small interfering RNA (siRNA) from the Univers...
...elgium, April 9 ThromboGenics NV,(Euronext Brusse...lar,diseases, eye diseases and cancer, announces t...ts Phase II MITI IV study. The primary purpose of,...ry efficacy of,microplasmin when administered intr...d twelve hours after the onset of the stroke., MI...
...April 8, 2008 Dendreon Corporation,(Nasdaq: DNDN...ously,announced registered direct offering of 8.0 ... purchase up to 8.0 million shares of its common,s...ximately $46 million.,Lazard Capital Markets LLC s...The offering is being made pursuant to previously ...
Other Biology Technology:Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School 2Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School 3Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School 4ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke 2ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke 3Dendreon Announces Closing of Registered Direct Offering 2
(Date:12/1/2009)...versity cancer researchers have developed a tumor... and blocks the growth of new tumor blood vessels.... kill cancer cells oncolytic viruses might be mo...ey also carry a gene for a protein that inhibits b...statin, is normally produced in the brain. In this...
(Date:12/1/2009)... attacks by sharks can be solved with a new techni...mp they put on their victims, according to a Unive...In a method analogous to analyzing human fingerpri...ely comparing shark bites to the jaws and teeth of...ctor of the International Shark Attack File, which...
(Date:12/1/2009)...bominable mystery, and it is a question which has ...id flowering plants evolve and how did they come t...Ecology Letters reveals the evolutionary trigger ...r competitive advantage over rival species, leadin...study, by Dr Tim Brodribb and Dr Taylor Field of ...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3How did flowering plants evolve to dominate Earth? 2Methane gas likely spewing into the oceans through vents in sea floor 9770 1Methane gas likely spewing into the oceans through vents in sea floor 9770 2Methane gas likely spewing into the oceans through vents in sea floor 9770 3Boron based compounds trick a biomedical protein 9768 1Boron based compounds trick a biomedical protein 9768 2Childrens Hospitals and Clinics of Minnesota Welcomes Twin Cities Businesswoman Molly Culligan to its Board of Directors 56066 1Childrens Hospitals and Clinics of Minnesota Welcomes Twin Cities Businesswoman Molly Culligan to its Board of Directors 56066 2
...ction between the body, mind and spirit has been t...some 20 years. The notion that psychosocial and so...ealth and preventing disease became crystallized a...Cousins. In the 1970s, Cousins, then a writer and ...s diagnosed with an autoimmune disease. He theoriz...
...ction affects millions of people around the world,...and psychological difficulties to physical and hea...uriosity or peer pressure, but in some animals, su...ul early life event, such as social isolation. A n...n the animal,s response to cocaine. , The study,...
...itute for Research in Immunology and Cancer (IRIC)...g a large quantity of laboratory stem cells from a...ne marrow. The multidisciplinary team, directed by... the development of a revolutionary treatment base...dvance stem cell research and could have major imp...
Other Biology News:Laughter remains good medicine 2Laughter remains good medicine 3Early isolation linked to enhanced response to cocaine 2World premiere in stem cell research in Montreal 2
BD Falcon TufRol Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
...lly clear polystyrene with frosted labeling surfac...s for cell counting. 100% integrity tested. Linkag...d to easily match Cornings product number. If show...d Sigma-Aldrich number (Z71,693-6) or contact cust...
...lly clear polystyrene with frosted labeling surfac...s for cell counting. 100% integrity tested. Linkag...d to easily match Cornings product number. If show...d Sigma-Aldrich number (C0177) or contact customer...
BD Falcon Automated Cell Culture Flask from BD Biosciences - Discovery Labware
Biology Products: